Estadístiques de Challenges with approved targeted therapies against recurrent mutations in CLL: a place for new actionable targets

Visites totals

views
Challenges with approved targeted therapies against recurrent mutations in CLL: a place for new actionable targets 58

Visites totals per mes

views
August 2024 1
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

Visites al fitxer

views
Lopez_can_chal.pdf(legacy) 51
Lopez_can_chal.pdf 9

Vistes principals per país

views
United States 48
Spain 4
Iran 2
Sweden 2
Japan 1
Malaysia 1

Visites principals per ciutat

views
San Ramon 22
Mountain View 6
Ashburn 4
Barcelona 3
Boardman 2
Fairfield 2
Redmond 2
San Diego 2
Ann Arbor 1
Cambridge 1
Fregenal De La Sierra 1
Menlo Park 1
Portland 1
Shah Alam 1
Tokyo 1